​

Editas Medicine (EDIT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Editas Medicine Revenue Highlights

00

Main Segment (Y)

Reportable Segment

Editas Medicine Revenue by Period

Editas Medicine Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$78.12M296.32%
2022-12-31$19.71M-22.83%
2021-12-31$25.54M-71.85%
2020-12-31$90.73M341.93%
2019-12-31$20.53M-35.71%
2018-12-31$31.94M132.64%
2017-12-31$13.73M126.80%
2016-12-31$6.05M271.58%
2015-12-31$1.63M100.00%
2014-12-31-100.00%
2013-12-31--

Editas Medicine generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Editas Medicine Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$513.00K-54.80%
2024-03-31$1.14M-98.11%
2023-12-31$60.05M1025.36%
2023-09-30$5.34M84.83%
2023-06-30$2.89M-70.69%
2023-03-31$9.85M50.72%
2022-12-31$6.54M15461.90%
2022-09-30$42.00K-99.34%
2022-06-30$6.36M-6.04%
2022-03-31$6.77M-45.70%
2021-12-31$12.47M101.21%
2021-09-30$6.20M1535.09%
2021-06-30$379.00K-94.17%
2021-03-31$6.50M-43.09%
2020-12-31$11.42M-81.83%
2020-09-30$62.84M484.62%
2020-06-30$10.75M87.82%
2020-03-31$5.72M-53.41%
2019-12-31$12.28M219.23%
2019-09-30$3.85M65.15%
2019-06-30$2.33M12.61%
2019-03-31$2.07M-66.19%
2018-12-31$6.12M-57.86%
2018-09-30$14.52M96.95%
2018-06-30$7.37M87.73%
2018-03-31$3.93M7.09%
2017-12-31$3.67M-41.63%
2017-09-30$6.28M102.84%
2017-06-30$3.10M354.11%
2017-03-31$682.00K-24.05%
2016-12-31$898.00K-6.65%
2016-09-30$962.00K-71.61%
2016-06-30$3.39M320.87%
2016-03-31$805.00K1.64%
2015-12-31$792.00K18.21%
2015-09-30$670.00K301.20%
2015-06-30$167.00K100.00%
2015-03-31-100.00%
2014-12-31--

Editas Medicine generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Editas Medicine Revenue Breakdown

Editas Medicine Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$32.31M

Editas Medicine's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Editas Medicine Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VRTXVertex Pharmaceuticals$11.02B$2.77B
DNAGinkgo Bioworks$227.04M$89.05M
CRSPCRISPR Therapeutics$37.31M$602.00K
VERVVerve Therapeutics$32.33M$6.87M
PRMEPrime Medicine$2.98M$39.31M
ALLOAllogene Therapeutics$22.00K-
NTLAIntellia Therapeutics-$9.11M
EDITEditas Medicine--
SANASana Bio--
CRBUCaribou Biosciences-$3.46M
BEAMBeam Therapeutics-$14.27M

EDIT Revenue FAQ

What is Editas Medicine’s yearly revenue?

Editas Medicine's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $78.12M, representing an increase of 296.32% compared to 2022. EDIT's yearly revenue for 2022 was $19.71M, representing a decrease of -22.83% compared to 2021.

What is Editas Medicine’s quarterly revenue?

Editas Medicine's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $513K, a -54.80% decrease from the previous quarter (Q1 2024), and a -82.23% decrease year-over-year (Q2 2023). EDIT's quarterly revenue for Q1 2024 was $1.14M, a -98.11% decrease from the previous quarter (Q4 2023), and a -88.48% decrease year-over-year (Q1 2023).

What is Editas Medicine’s revenue growth rate?

Editas Medicine's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Editas Medicine’s revenue streams?

Editas Medicine's revenue streams in c 24 are Reportable Segment

What is Editas Medicine’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Editas Medicine was Reportable Segment. This segment made a revenue of $32.31M, representing 100.00% of the company's total revenue.